LMO1 and neuroblastoma: By chromatin immunoprecipitation and sequencing (ChIP-seq) processing, Oldridge et al. found changed polymorphism within one SE element of LIM domain only 1 (LMO1) significantly affected neuroblastoma susceptibility by different binding of gamma-aminobutyrate (GATA) TF or regulation of LMO1 expression, which resulted in oncogenic dependency of neuroblastoma [8].